179 related articles for article (PubMed ID: 25822228)
1. Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.
Chen AC; Martin ML; Lourie R; Rogers GB; Burr LD; Hasnain SZ; Bowler SD; McGuckin MA; Serisier DJ
PLoS One; 2015; 10(3):e0119325. PubMed ID: 25822228
[TBL] [Abstract][Full Text] [Related]
2. A Th17- and Th2-skewed cytokine profile in cystic fibrosis lungs represents a potential risk factor for Pseudomonas aeruginosa infection.
Tiringer K; Treis A; Fucik P; Gona M; Gruber S; Renner S; Dehlink E; Nachbaur E; Horak F; Jaksch P; Döring G; Crameri R; Jung A; Rochat MK; Hörmann M; Spittler A; Klepetko W; Akdis CA; Szépfalusi Z; Frischer T; Eiwegger T
Am J Respir Crit Care Med; 2013 Mar; 187(6):621-9. PubMed ID: 23306544
[TBL] [Abstract][Full Text] [Related]
3. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis.
Kapur N; Grimwood K; Masters IB; Morris PS; Chang AB
Pediatr Pulmonol; 2012 Mar; 47(3):300-7. PubMed ID: 21901858
[TBL] [Abstract][Full Text] [Related]
4. PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.
Burr LD; Rogers GB; Chen AC; Taylor SL; Bowler SD; Keating RL; Martin ML; Hasnain SZ; McGuckin MA
PLoS One; 2018; 13(8):e0202296. PubMed ID: 30114278
[TBL] [Abstract][Full Text] [Related]
5. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
[TBL] [Abstract][Full Text] [Related]
6. Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.
Miao XY; Ji XB; Lu HW; Yang JW; Xu JF
Chin Med J (Engl); 2015 Oct; 128(20):2792-7. PubMed ID: 26481748
[TBL] [Abstract][Full Text] [Related]
7. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
[TBL] [Abstract][Full Text] [Related]
8. Th17 associated cytokines in sputum samples from patients with cystic fibrosis.
Oshalim M; Johansson E; Rabe H; Gilljam M; Lindblad A; Jönsson B
Pathog Dis; 2020 Sep; 78(6):. PubMed ID: 32876666
[TBL] [Abstract][Full Text] [Related]
9. Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients.
Fouka E; Lamprianidou E; Arvanitidis K; Filidou E; Kolios G; Miltiades P; Paraskakis E; Antoniadis A; Kotsianidis I; Bouros D
Lung; 2014 Dec; 192(6):849-55. PubMed ID: 25016929
[TBL] [Abstract][Full Text] [Related]
10. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
[TBL] [Abstract][Full Text] [Related]
11. Bu-Shen-Yi-Qi formulae suppress chronic airway inflammation and regulate Th17/Treg imbalance in the murine ovalbumin asthma model.
Wei Y; Luo QL; Sun J; Chen MX; Liu F; Dong JC
J Ethnopharmacol; 2015 Apr; 164():368-77. PubMed ID: 25625352
[TBL] [Abstract][Full Text] [Related]
12. Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis?
Hodge S; Upham JW; Pizzutto S; Petsky HL; Yerkovich S; Baines KJ; Gibson P; Simpson JL; Buntain H; Chen ACH; Hodge G; Chang AB
Chest; 2016 Feb; 149(2):508-515. PubMed ID: 26867834
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ
Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibodies (ANCA) in serum and bronchoalveolar lavage fluids of cystic fibrosis patients and patients with idiopathic bronchiectasis.
Cobanoğlu N; Ozcelik U; Cetin I; Yalçin E; Doğru D; Kiper N; Bakkaloğlu A
Turk J Pediatr; 2010; 52(4):343-7. PubMed ID: 21043377
[TBL] [Abstract][Full Text] [Related]
15. Effect of Pseudomonas aeruginosa on the expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in the airway of bronchiectasis patients.
Jin Q; Huang FH; Zhou Y; Zhang YQ; Chai XJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Aug; 34(4):384-9. PubMed ID: 22954123
[TBL] [Abstract][Full Text] [Related]
16. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis.
Sibila O; Suarez-Cuartin G; Rodrigo-Troyano A; Fardon TC; Finch S; Mateus EF; Garcia-Bellmunt L; Castillo D; Vidal S; Sanchez-Reus F; Restrepo MI; Chalmers JD
Respirology; 2015 Oct; 20(7):1082-8. PubMed ID: 26172851
[TBL] [Abstract][Full Text] [Related]
17. The Th17 pathway in cystic fibrosis lung disease.
Tan HL; Regamey N; Brown S; Bush A; Lloyd CM; Davies JC
Am J Respir Crit Care Med; 2011 Jul; 184(2):252-8. PubMed ID: 21474644
[TBL] [Abstract][Full Text] [Related]
18. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
[TBL] [Abstract][Full Text] [Related]
19. Immunity and bacterial colonisation in bronchiectasis.
Whitters D; Stockley R
Thorax; 2012 Nov; 67(11):1006-13. PubMed ID: 21933944
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.
Sousa GM; Oliveira IS; Andrade LJ; Sousa-Atta ML; Paraná R; Atta AM
Cytokine; 2012 Oct; 60(1):138-42. PubMed ID: 22748467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
